Waves Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-06-2024
- Paid Up Capital ₹ 0.97 M
as on 20-06-2024
- Company Age 23 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.10 M
as on 20-06-2024
- Revenue 5.71%
(FY 2020)
- Profit -30.74%
(FY 2020)
- Ebitda -19.49%
(FY 2020)
- Net Worth -1.15%
(FY 2020)
- Total Assets -0.05%
(FY 2020)
About Waves Bio-Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.97 M.
The company currently has active open charges totaling ₹5.10 M.
Suresh Kumar and Raj Kumar serve as directors at the Company.
- CIN/LLPIN
U24239DL2001PTC111836
- Company No.
111836
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Waves Bio-Tech Pvt Ltd offer?
Waves Bio-Tech Pvt Ltd offers a wide range of products and services, including Sexual Wellness, Sexual Health Supplements, Protein Supplements, Amino Acids.
Who are the key members and board of directors at Waves Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Kumar  | Director | 14-Jun-2005 | Current |
| Suresh Kumar | Director | 14-Jun-2005 | Current |
Financial Performance of Waves Bio-Tech.
Waves Bio-Tech Pvt Ltd, for the financial year ended 2020, experienced modest growth in revenue, with a 5.71% increase. The company also saw a substantial fall in profitability, with a 30.74% decrease in profit. The company's net worth dipped by a decrease of 1.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Waves Bio-Tech?
In 2020, Waves Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED_355366.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 05 Sep 2013 | ₹3.10 M | Open |
Corporation Bank Creation Date: 11 Nov 2001 | ₹2.00 M | Open |
How Many Employees Work at Waves Bio-Tech?
Waves Bio-Tech has a workforce of 51 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Waves Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waves Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
